Abstract
Background:
The ABO gene has been widely studied and associated with many different diseases such as myocardial infarction and diabetes. Pleiotropic effects of the ABO locus have been demonstrated. Indeed it affects different phenotypes such as E- and P-selectins, triglycerides and total cholesterol. The goal of this work was to study the SNP rs644234 located in the ABO gene with different phenotypes related with diseases where the ABO gene has been involved.
Methods:
We analyzed the SNP rs644234 located in the ABO gene, by performing association studies with different lipid phenotypes as well as with the soluble E-selectin levels in 348 adults from the STANISLAS Family Study.
Results:
The major rs644234*T allele was associated with increased levels of soluble E-selectin (p=8.7×10−12). According to the lipid phenotypes, the major rs644234*T allele was associated with decreased levels of apolipoproteins E (ApoE) (p=0.001) and low-density lipoprotein cholesterol (LDL-C) (p=0.032) but was associated with increased levels of high-density lipoprotein cholesterol (HDL-C) (p=0.013). The association of the HDL-C was especially significant in the male individuals (p=0.001).
Conclusions:
We confirmed that ABO is a major locus for serum soluble E-selectin levels variability, and we also correlated this gene with different lipid phenotypes. Furthermore, we demonstrated that this pleiotropic effect is independent. This is the first time that a correlation has been made between the ABO gene and the ApoE levels. According to these results, the major allele of this polymorphism may have a protective effect when it comes to cardiovascular related diseases, and more specifically when it comes to the lipid phenotypes.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009;25:48–59.10.21307/immunohematology-2019-231Search in Google Scholar
2. Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011;377:383–92.10.1016/S0140-6736(10)61996-4Search in Google Scholar
3. Bruzelius M, Bottai M, Sabater-Lleal M, Strawbridge RJ, Bergendal A, Silveira A, et al. Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors. J Thromb Haemost 2015;13:219–27.10.1111/jth.12808Search in Google Scholar PubMed
4. Rummel SK, Ellsworth RE. The role of the histoblood ABO group in cancer. Future Sci OA 2016;2:FSO107.10.4155/fsoa-2015-0012Search in Google Scholar PubMed PubMed Central
5. Vasan SK, Hwang J, Rostgaard K, Nyren O, Ullum H, Pedersen OB, et al. ABO blood group and risk of cancer: a register-based cohort study of 1.6 million blood donors. Cancer Epidemiol 2016;44:40–3.10.1016/j.canep.2016.06.005Search in Google Scholar PubMed
6. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978–86.10.1001/jama.291.16.1978Search in Google Scholar PubMed
7. Zhang H, Mooney CJ, Reilly MP. ABO blood groups and cardiovascular diseases. Int J Vasc Med 2012;2012:641917.10.1155/2012/641917Search in Google Scholar PubMed PubMed Central
8. Jenkins PV, O’Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 2006;46:1836–44.10.1111/j.1537-2995.2006.00975.xSearch in Google Scholar PubMed
9. Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q, et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 2010;19:1856–62.10.1093/hmg/ddq057Search in Google Scholar PubMed PubMed Central
10. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE, et al. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009;29:1958–67.10.1161/ATVBAHA.109.192971Search in Google Scholar PubMed PubMed Central
11. Kiechl S, Pare G, Barbalic M, Qi L, Dupuis J, Dehghan A, et al. Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet 2011;4:681–6.10.1161/CIRCGENETICS.111.960682Search in Google Scholar PubMed PubMed Central
12. Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008;4:e1000118.10.1371/journal.pgen.1000118Search in Google Scholar PubMed PubMed Central
13. Blann AD, Daly RJ, Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996;92:498–500.10.1046/j.1365-2141.1996.d01-1486.xSearch in Google Scholar PubMed
14. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD. The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 1998;102:145–52.10.1172/JCI3001Search in Google Scholar PubMed PubMed Central
15. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707–13.10.1038/nature09270Search in Google Scholar PubMed PubMed Central
16. Teupser D, Baber R, Ceglarek U, Scholz M, Illig T, Gieger C, et al. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 2010;3:331–9.10.1161/CIRCGENETICS.109.907873Search in Google Scholar PubMed
17. Teng MS, Hsu LA, Wu S, Chou HH, Chang CJ, Sun YZ, et al. Mediation analysis reveals a sex-dependent association between ABO gene variants and TG/HDL-C ratio that is suppressed by sE-selectin level. Atherosclerosis 2013;228:406–12.10.1016/j.atherosclerosis.2013.03.032Search in Google Scholar PubMed
18. Silbernagel G, Chapman MJ, Genser B, Kleber ME, Fauler G, Scharnagl H, et al. High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a meta-analysis. J Am Coll Cardiol 2013;62:291–9.10.1016/j.jacc.2013.01.100Search in Google Scholar PubMed
19. Yamagata University Genomic Cohort C. Pleiotropic effect of common variants at ABO glycosyltranferase locus in 9q32 on plasma levels of pancreatic lipase and angiotensin converting enzyme. PLoS One 2014;9:e55903.10.1371/journal.pone.0055903Search in Google Scholar PubMed PubMed Central
20. Klop B, van de Geijn GJ, Bovenberg SA, van der Meulen N, Elte JW, Birnie E, et al. Erythrocyte-bound apolipoprotein B in relation to atherosclerosis, serum lipids and ABO blood group. PLoS One 2013;8:e75573.10.1371/journal.pone.0075573Search in Google Scholar PubMed PubMed Central
21. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986–90.10.1038/ng.429Search in Google Scholar PubMed PubMed Central
22. Tanikawa C, Urabe Y, Matsuo K, Kubo M, Takahashi A, Ito H, et al. A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet 2012;44:430–4, S1–2.10.1038/ng.1109Search in Google Scholar PubMed
23. Germain M, Saut N, Greliche N, Dina C, Lambert JC, Perret C, et al. Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One 2011;6:e25581.10.1371/journal.pone.0025581Search in Google Scholar PubMed PubMed Central
24. Tregouet DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009;113:5298–303.10.1182/blood-2008-11-190389Search in Google Scholar PubMed
25. Visvikis-Siest S, Siest G. The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases. Clin Chem Lab Med 2008;46:733–47.10.1515/CCLM.2008.178Search in Google Scholar PubMed
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.10.1093/clinchem/18.6.499Search in Google Scholar
27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.10.1093/nar/16.3.1215Search in Google Scholar PubMed PubMed Central
28. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999;9:936–49.10.1101/gr.9.10.936Search in Google Scholar PubMed PubMed Central
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559–75.10.1086/519795Search in Google Scholar PubMed PubMed Central
30. Moinzadeh F, Najafabady GM, Toghiani A. Type 2 diabetes mellitus and ABO/Rh blood groups. J Res Med Sci 2014;19:382.Search in Google Scholar
31. Egawa N, Lin Y, Tabata T, Kuruma S, Hara S, Kubota K, et al. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer. World J Gastroenterol 2013;19:2537–42.10.3748/wjg.v19.i16.2537Search in Google Scholar PubMed PubMed Central
32. Badimon JJ, Santos-Gallego CG, Badimon L. Importance of HDL cholesterol in atherothrombosis: how did we get here? Where are we going? Rev Esp Cardiol 2010;63(Suppl 2): 20–35.Search in Google Scholar
33. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223–9.10.1002/path.1711710311Search in Google Scholar PubMed
34. Veniant MM, Withycombe S, Young SG. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice. Arterioscler Thromb Vasc Biol 2001;21:1567–70.10.1161/hq1001.097780Search in Google Scholar PubMed
35. Zhang H, Zhang Z, Zhang J, Xu L, Ye Z, Hao Y, et al. Fine-Mapping of ABO gene identifies two novel SNPs associated with large artery atherosclerotic stroke in a Chinese Han Population. Mol Neurobiol 2017;54:2107–13.10.1007/s12035-016-9794-5Search in Google Scholar PubMed
36. Gregersen PK, Behrens TW. Genetics of autoimmune diseases–disorders of immune homeostasis. Nat Rev Genet 2006;7:917–28.10.1038/nrg1944Search in Google Scholar PubMed
©2018 Walter de Gruyter GmbH, Berlin/Boston
